Identification of the dopaminergic neurotoxin 1-trichloromethyl-1,2, 3,4-tetrahydro-beta-carboline in human blood after intake of the hypnotic chloral hydrate.

1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a potent toxin toward dopaminergic neurons, readily originates in vitro from the biogenic amine tryptamine and the unnatural aldehyde chloral. For this reason, this heterocycle has been postulated to be formed endogenously in humans after administration of the hypnotic chloral hydrate or after exposure to the industrial solvent trichloroethylene by a spontaneous chemical ring closure reaction. In this paper, we report on the first identification of TaClo in blood samples of patients treated orally with chloral hydrate. Using a specific and sensitive gas chromatographic screening procedure based upon electron-capture and mass-selective detection, TaClo was determined after conversion to its volatile trifluoroacetyl derivative. The identity of TaClo in humans was clearly demonstrated by GC-MS analysis in selected-ion-monitoring mode, by the characteristic chlorine isotopic pattern of the molecular ion.

[1]  A. Moser Pharmacology of Endogenous Neurotoxins , 2012, Birkhäuser Boston.

[2]  H. Reichmann,et al.  Effect of highly halogenated β‐carbolines on dopaminergic cells in culture and on mitochondrial respiration , 1999 .

[3]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1976 .

[4]  E. Pellizzari Electron capture detection in gas chromatography , 1974 .

[5]  K. Sontag,et al.  The halogenated tetrahydro-beta-carboline "TaClo": a progressively-acting neurotoxin. , 1997, Journal of neural transmission. Supplementum.

[6]  H. Reichmann,et al.  Neurotoxic effects on the dopaminergic system induced by TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline), a potential mammalian alkaloid : in vivo and in vitro studies , 1996 .

[7]  P. Riederer,et al.  Biochemical lesions of the nigrostriatal system by TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) and derivatives. , 1995, Journal of neural transmission. Supplementum.

[8]  H. Reichmann,et al.  The TaClo concept: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a new toxin for dopaminergic neurons. , 1995, Journal of neural transmission. Supplementum.

[9]  H. Reichmann,et al.  1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline, a new inhibitor of complex I. , 1995, Journal of neural transmission. Supplementum.

[10]  R. Ramsay,et al.  Biochemical mechanisms underlying MPTP-induced and idiopathic parkinsonism. New vistas. , 1993, Advances in neurology.

[11]  G. Bringmann,et al.  Endogenous Alkaloids in Man, VII1): 1‐Trichloromethyl‐1,2,3,4‐tetrahydro‐β‐carboline ‐ A Potential Chloral‐Derived Indol Alkaloid in Man , 1990 .

[12]  J. Blancato,et al.  Metabolism, toxicity, and carcinogenicity of trichloroethylene. , 1989, Critical reviews in toxicology.

[13]  A. Rizzo,et al.  Derivatization of trichothecenes and water treatment of their trimethylsilyl ethers in an anhydrous apolar solvent , 1986 .